Podcasts about c difficile

Learn about Serum Bovine Immunoglobulin (SBI) Powder, a game-changer in gut health with Brian Kaufman, RN, Vice President of Global Business Development for Proliant Health & Biologicals. By selectively removing gut pathogens without disturbing commensal bacteria, SBIs help in conditions as diverse as SIBO, IBS, Candida, Crohn's, colitis, malnutrition, leaky gut, cancer, HIV, psoriasis and acute gut infections like C Difficile. Learn how this plasma-derived bovine immunoglobulin (IgG) supplement facilitates gut healing and improves nutrient absorption while preserving the microbiome. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Tiktok, X, Instagram or Pinterest or reach her via email at lindsey@highdeserthealthcoaching.com to set up a free 30-minute Gut Healing Breakthrough Session. Show Notes

Peggy Lillis wasn't expecting trouble when her dentist prescribed antibiotics after she had a root canal in 2010. It was a standard, just-in-case treatment to prevent infections after the procedure.She also wasn't worried when she developed diarrhea soon afterward. The kindergarten teacher assumed she'd caught a bug from one of her young students.But within just a few days, the previously healthy 56-year-old was dead – a victim of Clostridioides difficile or C. diff. These bacteria are common but can grow out of control when antibiotics or other factors deplete the healthy microbes living in the intestines – the microbiome.Patients can suffer severe diarrhea, a distortion of the colon known as megacolon, and sepsis as the infection spreads to the bloodstream. It's painful and can be hard to treat.About one out of every six patients who get C. diff will get it again in the following two months, the U.S. Centers for Disease Control and Prevention says. Such infections kill 1 out of 11 people over the age of 65 who develop a C. diff infection in the hospital.It's a One Health problem, as the bacteria spread globally.Antibiotics are not always effective in treating C. diff. because these bacteria thrive when the natural population of microbes is killed off. Instead, many doctors are turning to treatments that can replace the healthy microbiome. These can include fecal microbiota transplants (FMTs), also known as poop transplants, or therapies that more directly replace the “good” microbes.Peggy Lillis' sons, Christian and Liam, didn't want her death to have been in vain, so they founded the Peggy Lillis Foundation to advocate for awareness of C. diff, public policy to fight it, and for better treatments.Christian Lillis says he will never get over losing his mother to C. diff.  “It remains the worst thing that has ever happened to me,” he tells One World, One Health host Maggie Fox. In this episode, Lillis tells us about this dangerous repercussion of the misuse and overuse of antibiotics, the need for new treatments, and what survivors and family members can do to take action against C. diff.

In this episode, Martin Talks to Dr Mark Wilcox OBE, Professor of Microbiology at the University of Leeds, Head of Microbiology Research & Development at Leeds University Hospitals NHS Trust and National Clinical Director for Infection Prevention and Control at NHS England. We mull over the possible reasons for the increase in hospital-onset, hospital attributed cases in England, including ribotypes and antibiotic use. Given that the NHS is under great stress, we discuss the damage potential from a ribotype 955 which shares some genetic characteristics with the 027 ribotype that caused so many problems in the UK and worldwide in the early 2000s. One thing that we agree on is that reductions targets (with teeth) have been very successful in the past and should we venture in that direction again? Information on data collection, hospital and national typing reports for England can be found here: https://www.gov.uk/government/collections/clostridium-difficile-guidance-data-and-analysis#epidemiology

In this episode, Martin Talks to Dr Mark Wilcox OBE, Professor of Microbiology at the University of Leeds, Head of Microbiology Research & Development at Leeds University Hospitals NHS Trust and National Clinical Director for Infection Prevention and Control at NHS England. We mull over the possible reasons for the increase in hospital-onset, hospital attributed cases in England, including ribotypes and antibiotic use. Given that the NHS is under great stress, we discuss the damage potential from a ribotype 955 which shares some genetic characteristics with the 027 ribotype that caused so many problems in the UK and worldwide in the early 2000s. One thing that we agree on is that reductions targets (with teeth) have been very successful in the past and should we venture in that direction again? Information on data collection, hospital and national typing reports for England can be found here: https://www.gov.uk/government/collections/clostridium-difficile-guidance-data-and-analysis#epidemiology

In this episode, after an interesting discovery when searching Youtube, Brett and Martin mull over whether toilet plume is a risk factor for hospital-acquired pneumonia and C. difficile infections. The papers we discuss are listed below. Goforth MP, Boone SA, Clark J, Valenzuela PB, McKinney J, Ijaz MK, et al. Impacts of lid closure during toilet flushing and of toilet bowl cleaning on viral contamination of surfaces in United States restrooms. Am J Infect Control 2023. https://doi.org/10.1016/j.ajic.2023.11.020 Best EL, Sandoe JA, Wilcox MH. Potential for aerosolization of Clostridium difficile after flushing toilets: the role of toilet lids in reducing environmental contamination risk. J Hosp Infect 2012;80(1):1-5. https://doi.org/10.1016/j.jhin.2011.08.010 Lai ACK, Tan TF, Li WS, Ip DKM. Emission strength of airborne pathogens during toilet flushing. Indoor Air 2018;28(1):73-9. https://doi.org/10.1111/ina.12406

In this episode, after an interesting discovery when searching Youtube, Brett and Martin mull over whether toilet plume is a risk factor for hospital-acquired pneumonia and C. difficile infections. The papers we discuss are listed below. Goforth MP, Boone SA, Clark J, Valenzuela PB, McKinney J, Ijaz MK, et al. Impacts of lid closure during toilet flushing and of toilet bowl cleaning on viral contamination of surfaces in United States restrooms. Am J Infect Control 2023. https://doi.org/10.1016/j.ajic.2023.11.020 Best EL, Sandoe JA, Wilcox MH. Potential for aerosolization of Clostridium difficile after flushing toilets: the role of toilet lids in reducing environmental contamination risk. J Hosp Infect 2012;80(1):1-5. https://doi.org/10.1016/j.jhin.2011.08.010 Lai ACK, Tan TF, Li WS, Ip DKM. Emission strength of airborne pathogens during toilet flushing. Indoor Air 2018;28(1):73-9. https://doi.org/10.1111/ina.12406

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt MD, FACG, AGAF C. difficile is a major problem in the United States. On top of that, patients who are diagnosed with this infection have the chance of getting caught in a vicious cycle of recurrence. So how can we provide our patients with the best care and work with them to give them the best treatment option? Learn more with Dr. Peter Buch as he takes a deep dive with Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale-New Haven Hospital.

We sit down with Carol Raye, a patient advocate who shares her personal journey with a life-threatening C. difficile infection. Join us as Carol sheds light on the challenges she faced, the importance of responsible antibiotic use, and her mission to raise awareness about this growing health care issue. Discover how her experience has shaped her advocacy work and the urgent need for better treatment options. Carol Raye is a patient advocate. She discusses the KevinMD article, "A life-changing illness started with a popcorn kernel and just-in-case treatment." Our presenting sponsor is Nuance, a Microsoft company. Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care's biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself. The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational. Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/BqhNvT Powered by CMEfy. 

Olivia Ostrow on the management of button battery ingestions, Brit Long on C difficile infection, Jesse McLaren on an approach to ECG's in the tox patient, Joe Mullally on the identification and treatment of bed bug bites, Andrew Petrosoniak on fibrinogen replacement in bleeding trauma patients, Justin Morganstern on Cold Air for Croup... The post EM Quick Hits 54 Button Battery Ingestion, C. difficile, ECG in Tox, Bed Bugs, Fibrinogen in Trauma, Cold Air for Croup appeared first on Emergency Medicine Cases.

CME credits: 0.75 Valid until: 15-06-2024 Claim your CME credit at https://reachmd.com/programs/cme/the-gut-microbiome-an-evidence-based-approach-to-managing-recurrent-c-difficile-infection/16391/ Explore this series of three modules on C difficile infection and the impact of gut dysbiosis on the development of recurrent disease with Dr. Colleen Kelly, Associate Professor of Medicine in the Division of Gastroenterology at Warren Alpert Medical School of Brown University in Providence, Rhode Island, and Andrea Banty, Nurse Practitioner of Gastroenterology at Cedars-Sinai IBD Center in Los Angeles.=

In this week's episode, Martin talks to Dr Tina Joshi, Associate Professor of Molecular Microbiology in Peninsula Dental School at the University of Plymouth, UK. We discuss her longstanding interest in Clostridioides difficile and her many publications, one of which on the effectiveness of hypochlorite (or lack of it) on spores has been widely covered in the media. We chat about spore attachment to surfaces, the effect of disinfectants and the differences between strains. Some of Tina's papers are listed here. Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L. Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol 2012;78(21):7671-9. https://doi.org/10.1128/AEM.01862-12 Joshi LT, Welsch A, Hawkins J, Baillie L. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores. Lett Appl Microbiol 2017;65(3):199-205. https://doi.org/10.1111/lam.12768 Dyer C, Hutt LP, Burky R, Joshi LT. Biocide Resistance and Transmission of Clostridium difficile Spores Spiked onto Clinical Surfaces from an American Health Care Facility. Appl Environ Microbiol 2019;85(17). https://doi.org/10.1128/AEM.01090-19 Waterfield S, Ahmed H, Jones IA, Burky R, Joshi LT. Isolation of Clostridioides difficile PCR Ribotype 027 from single-use hospital gown ties. J Med Microbiol 2022;71(6). https://doi.org/10.1099/jmm.0.001550 Ahmed H, Joshi LT. Clostridioides difficile spores tolerate disinfection with sodium hypochlorite disinfectant and remain viable within surgical scrubs and gown fabrics. Microbiology (Reading) 2023;169(11). https://doi.org/10.1099/mic.0.001418 Malyshev D, Jones IA, McKracken M, Oberg R, Harper GM, Joshi LT, et al. Hypervirulent R20291 Clostridioides difficile spores show disinfection resilience to sodium hypochlorite despite structural changes. BMC Microbiol 2023;23(1):59. https://doi.org/10.1186/s12866-023-02787-z.

In this week's episode, Martin talks to Dr Tina Joshi, Associate Professor of Molecular Microbiology in Peninsula Dental School at the University of Plymouth, UK. We discuss her longstanding interest in Clostridioides difficile and her many publications, one of which on the effectiveness of hypochlorite (or lack of it) on spores has been widely covered in the media. We chat about spore attachment to surfaces, the effect of disinfectants and the differences between strains. Some of Tina's papers are listed here. Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L. Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol 2012;78(21):7671-9. https://doi.org/10.1128/AEM.01862-12 Joshi LT, Welsch A, Hawkins J, Baillie L. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores. Lett Appl Microbiol 2017;65(3):199-205. https://doi.org/10.1111/lam.12768 Dyer C, Hutt LP, Burky R, Joshi LT. Biocide Resistance and Transmission of Clostridium difficile Spores Spiked onto Clinical Surfaces from an American Health Care Facility. Appl Environ Microbiol 2019;85(17). https://doi.org/10.1128/AEM.01090-19 Waterfield S, Ahmed H, Jones IA, Burky R, Joshi LT. Isolation of Clostridioides difficile PCR Ribotype 027 from single-use hospital gown ties. J Med Microbiol 2022;71(6). https://doi.org/10.1099/jmm.0.001550 Ahmed H, Joshi LT. Clostridioides difficile spores tolerate disinfection with sodium hypochlorite disinfectant and remain viable within surgical scrubs and gown fabrics. Microbiology (Reading) 2023;169(11). https://doi.org/10.1099/mic.0.001418 Malyshev D, Jones IA, McKracken M, Oberg R, Harper GM, Joshi LT, et al. Hypervirulent R20291 Clostridioides difficile spores show disinfection resilience to sodium hypochlorite despite structural changes. BMC Microbiol 2023;23(1):59. https://doi.org/10.1186/s12866-023-02787-z.

Our special guest, Julie Ann Davey, RN, MSN, ANP-C, ACNP-C, will discuss why frequent antacid use for heartburn is ruining your health. Welcome to Humanized! Each week, we feature top experts in personalized health and functional medicine through engaging interviews and presentations. You'll get practical advice on diet and nutrition, lifestyle, toxins and disease, hormone imbalances, nutrient deficiencies, inflammation, digestive health, mental health, the fast-changing world of genomics, and so much more. All presentations are available as videos, podcasts or transcripts – whichever form is most convenient and enjoyable for you! Visit us at: https://humanizedhealth.com Subscribe to get weekly updates at: https://omniform1.com/signup/v1/5e736dfb8a48f751fdd6aa8a_604bd3c799f0b7086d1de9a4.html

Does longer treatment of C. difficile infection lead to fewer recurrences in patients taking concurrent antibiotics? Join us as we interview Irina Rajakumar on her research into the impact of CDI length of treatment on recurrent rates. Hear her discuss the study design and the impact of demographics such as age, clinical services, and concurrent antibiotics, and analyze if an infectious disease consultation influenced the outcome. Tune in to learn more about her work and how it can be applied to practice. With special guest: Irina Rajakumar, Infectious Disease and Antimicrobial Stewardship Pharmacist, Alberta Health Services

What a trilobite ate and what ate it; Antimatter falls down, much to the relief of physicists; Hospitals have controlled C. difficile outbreaks — but people are bringing their own; Some early cows – and cowboys – in the Americas came from Africa; Ugly babies: A new book looks at cute-challenged but fascinating baby animals.

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Sahil Khanna, M.B.B.S., M.S. It's estimated that C. difficile causes about a half million infections each year in the U.S. and 1 in 6 of those will have a recurrence within a couple months. Although C. difficile typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. What are the common symptoms of an infection with C. difficile? How do we test for it? How should an infection be treated and what do we do with patients who have one or more recurrences. In this podcast, we'll be discussing “What's New with C. Difficile?” and these are some of the questions I'll be asking our guest, Sahil Khanna, M.B.B.S., M.S., a gastroenterologist from the Mayo Clinic. Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Clostridium difficile (“C. difficile” or “C. diff”) can cause a Clostridium difficile Infection (CDI), a life-threatening diarrhea which is usually a side-effect of taking antibiotics. C. diff can easily spread from person to person and is considered a major health threat. There are an estimated 500,000 cases per year in the USA alone and close to 300,000 in hospitalized patients with around 29,000 deaths each year mostly from seniors and children. Doctor's Biome Medical Food, a very powerful version of Doctor's Biome Colon Health food supplement has been developed to help save lives and suffering from this horrible infection. Doctor's Biome Colon Health food supplement has been proven (and published in the Journal of Gastroenterology Research) to COMPLETELY SUPPRESS C. difficile infection in laboratory experiments and has shown amazing and remarkable healing results in patients with C. diff (and virtually all digestive diseases and conditions). Today we are announcing an offer of a FREE Open Clinical Trial of Doctor's Biome Medical Food (IRB controlled) to the first 100 patients who sign up. The details of the study will be fully discussed as well as what you need to do to participate. You have nothing to lose and the life you save may be your own.

Clostridium difficile (“C. difficile” or “C. diff”) can cause a Clostridium difficile Infection (CDI), a life-threatening diarrhea which is usually a side-effect of taking antibiotics. C. diff can easily spread from person to person and is considered a major health threat. There are an estimated 500,000 cases per year in the USA alone and close to 300,000 in hospitalized patients with around 29,000 deaths each year mostly from seniors and children. Doctor's Biome Medical Food, a very powerful version of Doctor's Biome Colon Health food supplement has been developed to help save lives and suffering from this horrible infection. Doctor's Biome Colon Health food supplement has been proven (and published in the Journal of Gastroenterology Research) to COMPLETELY SUPPRESS C. difficile infection in laboratory experiments and has shown amazing and remarkable healing results in patients with C. diff (and virtually all digestive diseases and conditions). Today we are announcing an offer of a FREE Open Clinical Trial of Doctor's Biome Medical Food (IRB controlled) to the first 100 patients who sign up. The details of the study will be fully discussed as well as what you need to do to participate. You have nothing to lose and the life you save may be your own.

Join our experts as they discuss the role of probiotics in Clostridioides difficile infection (CDI), review the differences between traditional fecal microbiota transplant and emerging live biotherapeutic products (LBP), and summarize the expanded indications and safety profiles of LBP pipeline drugs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

FDA revoke Emergency Use Authorization for a COVID-19 vaccine; New approval for treatment of iron deficiency in patients with heart failure; Lumryz now available for excessive daytime sleepiness; Vowst approved for C. difficile infection; Prevymis approved for prophylaxis of CMV disease in adult kidney transplant recipients.

Join our experts as they review the current epidemiology of Clostridioides difficile infection (CDI), discuss the risks and complications associated with recurrent CDI, and compare and contrast live biotherapeutic products (LBPs) and traditional fecal microbiota transplantation (FMT). The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Clostridioides difficile, a.k.a. C. diff is a horrible infection.500,000 people a year get it from simply using antibiotics or from coming in contact with contaminated clothing or surfaces in bathrooms. IT KILLS 28,000 PEOPLE A YEAR FROM UNCONTROLLABLE DIARRHEA. One in 11 people get it from using antibiotics.I in six people get recurrent bouts of it. 80 people a day die. Doctor's Biome Colon Health Medical Food, a delicious special probiotic drink has been proven in independent laboratory tests as well using it in patients to COMPLETELY SUPPRESS C. diff! We will discuss how C. diff. effects your body, how to prevent it if possible and how to get into the FREE Open Clinical Trial that will be starting soon to help in the dietary management of it. This is a must listen to show for anyone who has it.

Clostridioides difficile, a.k.a. C. diff is a horrible infection.500,000 people a year get it from simply using antibiotics or from coming in contact with contaminated clothing or surfaces in bathrooms. IT KILLS 28,000 PEOPLE A YEAR FROM UNCONTROLLABLE DIARRHEA. One in 11 people get it from using antibiotics.I in six people get recurrent bouts of it. 80 people a day die. Doctor's Biome Colon Health Medical Food, a delicious special probiotic drink has been proven in independent laboratory tests as well using it in patients to COMPLETELY SUPPRESS C. diff! We will discuss how C. diff. effects your body, how to prevent it if possible and how to get into the FREE Open Clinical Trial that will be starting soon to help in the dietary management of it. This is a must listen to show for anyone who has it.

Large recall of drugs due to company shutdown; First orally administered fecal microbiota treatment given green light; Treatment approved for certain ALS patients; Type 2 diabetes insulin delivery system; FDA issue safety alert concerning eyedrops.

Needed somewhere to post my project. I'm no professional but one day I will be better at putting audio together. C. diff are bacteria (germs) that cause diarrhea and colitis (an inflammation of the colon). C. diff infections can be life-threatening. They are obligate anaerobic, gram-positive rods, measuring 3–5 μm in length and 0.5 μm in width. They are capsulated, motile by peritrichous flagella and sporulating in nature. Some strains that also contain C. difficile bacteria enter the body through the mouth. It is estimated to cause almost half a million infections in the United States each year. C. diff can affect anyone. Most cases of C. diff occur when you have been taking antibiotics or not long after you have finished taking antibiotics.

Dr. Paul Feuerstadt, a gastroenterologist joins the podcast to discuss all things C diff in this edition of the PV Roundup specialist spotlight.

In this episode I am joined by Dr. Alaa Atmna, senior lecturer at Tel Aviv University and consultant for transplant infectious diseases at Beilinson Hospital in Israel. We are discussing UTI's, C Difficile in transplant, and more.

Host: Neilanjan Nandi, MD Guest: Monika Fischer, MD Clostridioides difficile, or C. difficile for short, is a bacteria that continues to plague our patients. What are the latest treatment updates that you need to be aware of? Dr. Neil Nandi is joined by Dr. Monika Fischer from Indiana University to dive into treatment options and discuss the latest updates.

Confira os temas do check-up de hoje: o que há de novo em pneumonia comunitária grave, antibióticos profiláticos em cirurgias colorretais, cetamina na UTI pediátrica, Clostridium difficile no Brasil e progestágeno por SIU ou por via vaginal na hiperplasia de endométrio. Ouça o episódio!

This episode will focus solely on the prevention of C. difficile as prevention is the best way to Not have to deal with it. In addition we discuss not only the safe and natural treatment for it in detail but how to prevent recurrence, even years after the initial infection seemed resolved. As last weeks Part 1 discussed, everyone is susceptible to this horrible, common life taking infection. Traditional medicine has failed for many. This show is dedicated to those whom it has miserably failed and now living their life in misery.C. diff. can be safely CURED!

In this study Dr. Sood and colleagues explore if the risk of a patient getting Clostridioides difficile Infection (CDI) is higher if the room was previously occupied by a C. diff patient. Previous single-center studies suggest that exposure to a room previously occupied by a patient with C. diff infection (CDI) may increase the risk of C. diff infection in subsequent patients. Dr. Sood and colleagues evaluated the risk of previous room occupant on CDI risk across 5 adult hospitals. With special guest: Geetika Sood, MD ScM Johns Hopkins University School of Medicine, Hospital Epidemiologist and Assistant Professor- John Hopkins Baltimore Medical Center and Health Service Researcher – JHHS

This episode will focus solely on the prevention of C. difficile as prevention is the best way to Not have to deal with it. In addition we discuss not only the safe and natural treatment for it in detail but how to prevent recurrence, even years after the initial infection seemed resolved. As last weeks Part 1 discussed, everyone is susceptible to this horrible, common life taking infection. Traditional medicine has failed for many. This show is dedicated to those whom it has miserably failed and now living their life in misery.C. diff. can be safely CURED!

C. diff (also known as Clostridioides difficile or C. difficile) is a bacterium that causes severe diarrhea and severe inflammation of the gut. This bacterium is everywhere in the environment, and produces spores that are extremely hard to kill. It lays asleep in our gut until we are given antibiotics that kill all the good biome (probiotics) in our gut allowing it to come alive and overgrow. It's estimated to cause almost half a million infections in the United States each year killing 28-30,000 people, mostly seniors and children. About 1 in 6 patients who get C. diff will get it again within 2-8 weeks. One in 11 people over age 65 diagnosed with a healthcare-associated C. diff infection die within one month. It is a nightmare to everyone who gets it and to their families. It will frequently recur and then the chance of further recurrences goes up to 40-60%! The current treatments cause many problems and are dangerous as well. We will discuss how to safely treat this life taking infection and offer an extremely safe and highly effective natural way to cure it!

C. diff (also known as Clostridioides difficile or C. difficile) is a bacterium that causes severe diarrhea and severe inflammation of the gut. This bacterium is everywhere in the environment, and produces spores that are extremely hard to kill. It lays asleep in our gut until we are given antibiotics that kill all the good biome (probiotics) in our gut allowing it to come alive and overgrow. It's estimated to cause almost half a million infections in the United States each year killing 28-30,000 people, mostly seniors and children. About 1 in 6 patients who get C. diff will get it again within 2-8 weeks. One in 11 people over age 65 diagnosed with a healthcare-associated C. diff infection die within one month. It is a nightmare to everyone who gets it and to their families. It will frequently recur and then the chance of further recurrences goes up to 40-60%! The current treatments cause many problems and are dangerous as well. We will discuss how to safely treat this life taking infection and offer an extremely safe and highly effective natural way to cure it!

In this episode, Dr. Sheliza Halani interviews special guest Dr. Alon Vaisman (Infectious Diseases) on the Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).They discuss the definitions of severity of C. difficile, recommendations for current treatment and testing, prophylaxis and surgical management options. Producer and Host: Dr. Sheliza HalaniGuest: Dr. Alon Vaisman (Infectious Diseases)Sound Editing: Dr. Alison LaiSupport the show

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt MD, FACG, AGAF In the United States, about 80 percent of tests used to diagnose C. difficile are PCR assays. So what are the best options to diagnose and treat patients with this infection? To discuss the evolving treatment and evaluation landscape for C. difficile, Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor at Yale New Haven Hospital.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

Dr. Cynthia Mayer, Infectious Diseases Clinician at the Infectious Diseases Associates of Tampa Bay, presents a review of Clostridium difficile infection. Dr. Mayer reviews the proposed etiologies of C difficile infection. She then covers the clinical presentation of C difficile infection and reviews the relevant examination criteria. Next, Dr. Mayer summarizes the treatment and management options for Clostridium difficile based upon the specific etiology. Lastly, the speaker discusses appropriate infection control management strategies.

One of the consequences of the “Antibiotic Era” has been the increased occurrence of infections caused by Clostridioides difficile, also known as “Cdiff”, which in some cases can be life-threatening.  Antibiotics alter the microbes that live in the gastrointestinal tract (the “microbiome”) allowing Cdiff to thrive and cause disease. Dr. Vincent Young is professor in the departments of Internal Medicine and Microbiology and Immunology at the University of Michigan Medical School.  Dr. Young is an expert on Cdiff and its interactions with the microbiome.  Dr. Young discusses how Cdiff infections have increased over the past several decades, how fecal transplants have been wildly successful at treating recurrent Cdiff infections, how banking fecal samples can be beneficial, how the gastrointestinal microbiome can influence Cdiff infection, and how playing keyboard in a band has been an important side job.  The MicroCase for listeners to solve is about Speedy Marathon, a cross-country runner who gets more than just a shrimp on the barbie when he runs Down Under.  Participants: Karl Klose, Ph.D. (UTSA) Vincent Young, M.D., Ph.D. (Univ. of Michigan) Janakiram Seshu, Ph.D. (UTSA) Mylea Echazarreta (UTSA)  

“Introducing a New Disinfection Technology Against C. diff.” Jordan Bastian (Speaker) Infection Preventionist, CloroxPro Clinical and Scientific Affairs, Clorox Company Ibezapolstat Update: Can Emerging Microbiome Findings Contribute to CDI Anti-Recurrence Effect? Kevin Garey (Speaker) Chair of the Department of Pharmacy Practice and Translational Research and Professor of Pharmacy Practice, University of Houston College of Pharmacy More Than a CDI: The Revolving Door and a Ray Of Hope. Kathy Bischoff (Speaker) Coordinator, VHA Program, C Diff Foundation Sponsored by ACURX Pharmaceuticals Clorox Healthcare

“Introducing a New Disinfection Technology Against C. diff.” Jordan Bastian (Speaker) Infection Preventionist, CloroxPro Clinical and Scientific Affairs, Clorox Company Ibezapolstat Update: Can Emerging Microbiome Findings Contribute to CDI Anti-Recurrence Effect? Kevin Garey (Speaker) Chair of the Department of Pharmacy Practice and Translational Research and Professor of Pharmacy Practice, University of Houston College of Pharmacy More Than a CDI: The Revolving Door and a Ray Of Hope. Kathy Bischoff (Speaker) Coordinator, VHA Program, C Diff Foundation Sponsored by ACURX Pharmaceuticals Clorox Healthcare

In this spore-tacular episode of Breakpoints, Drs. Anne Gonzales-Luna (@anniejayTX) and Paul Feuerstadt (@DrPaulGastro) join Dr. Rachel Britt (@rachelbpharmd) to discuss the microbiome, its relationship to C. difficile, and the new area of microbiota-based live biotherapeutic products (LBPs). This podcast was sponsored by an unrestricted medical education grant from Ferring Pharmaceuticals. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/ Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 4 --- 'Using a Gut Model to Predict Which Antibiotics Are Associated with CDI and Which Ones Best Treat CDI' Mark Wilcox, MD, FRCPath (Speaker) Consultant Microbiologist, Head of Microbiology and Academic Lead of Pathology, Leeds Teaching Hospitals --- Microbiome Therapeutics in 2021: Almost there for C difficile! Sahil Khanna, MBBS MS (Speaker) Professor of Medicine in the Division of Gastroenterology and Hepatology,, Mayo Clinic --- We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 4 --- 'Using a Gut Model to Predict Which Antibiotics Are Associated with CDI and Which Ones Best Treat CDI' Mark Wilcox, MD, FRCPath (Speaker) Consultant Microbiologist, Head of Microbiology and Academic Lead of Pathology, Leeds Teaching Hospitals --- Microbiome Therapeutics in 2021: Almost there for C difficile! Sahil Khanna, MBBS MS (Speaker) Professor of Medicine in the Division of Gastroenterology and Hepatology,, Mayo Clinic --- We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021. Episode 3 Update on the Development of Gut Microbiome Protectors from Antibiotic-Induced Dysbiosis. Florence Sejourne (Speaker) CEO, DA VOLTERRA --- “Safety and Efficacy of Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent Clostridioides difficile Infection: A Data Summary From Five Prospective Studies” Beth Guthmueller (Speaker) Rebiotix, a Ferring Company --- ‘CP101, an Investigational Orally Administered Microbiome Therapeutic Designed to Prevent Recurrent CDI' Shrish Budree (Speaker) Medical Director, Head of Clinical Microbiome Science, Finch Therapeutics --- We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast! This week, Drs. Mike and John Fralick do a Rapid Fire session to discuss two recent papers exploring if an oral microbiome replacement therapy reduces risk of recurrent C. difficile infection and if treating mild chronic hypertension in pregnancy improves ... The post Episode 39 – Hypertension in Pregnancy and Oral Mircrobiome Therapy in Recurrent C. difficile Infection appeared first on Healthy Debate.

Dr. Aaron Miller, a research assistant professor at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, and Sarah Gregory discuss transmission of C. difficile to family members from recently hospitalized patients.

The Case:  Meghan O'Rourke spent years describing her symptoms to her doctor only to be told it was something inconsequential or all in her head. After years of feeling alone and abandoned by the system she started to see a functional medicine practitioner. Finally, she was getting the real answers to what was going on but it took years to undo the damage done by dismissing the issues. She wrote a book about her experience to help others feel less alone.    The Investigation Many people dealing with autoimmune diseases or rare genetic issues find themselves beyond the textbooks of traditional medicine.  This can lead to being given false diagnosis (like, dry skin or hormonal shifts due to menses), or being sent off to specialist after specialist without any diagnosis. When you are caught in this loop, it seems like treating the issues is impossible and the journey can be emotionally draining.  The most heartbreaking part is that women who find themselves in this situation start to question if there are any answers out there, if maybe it is all in their head, or if they will ever feel well again.  This is often when they find me and I'm always so glad when they do and I can help to solve their health mysteries. I feel it's my purpose to help them get out of despair and on the road to health.   The Invisible Kingdom Meghan O'Rourke is on the same mission. In her book, The Invisible Kingdom, she shares her own journey and what it took to reclaim her health. She shares this story and everything she learned along the way so that others will know that they are not alone and that there are answers when you know where to look.  The book is completely aligned with this podcast, so if you're a long-time listener, you'll understand why I had to have her on the show.  In this episode, we break from our usual podcast format so that Meghan can share her inspirational story.    Meghan's Personal Health Mystery Story For over 10 years, Meghan dealt with health issues that no doctor could explain. It started with neurological symptoms like when she started to feel electrical shock sensations run up her leg. The doctor told her it might be dry skin. Then she started to experience vertigo, fatigue, daily hives, brain fog, joint pain, and excessive night sweats. While certain symptoms were treated others were blamed on stress or she was told not to worry about them.  Much like gaslighting, she started to question whether she was actually feeling these things. She started to buy into this message that something was wrong with her mind. She started to blame her diet and that everything she was experiencing was somehow her fault.  Eventually, she was diagnosed with Lyme Disease. She was also diagnosed with a genetic condition as well as Hashimoto's. This is when she realized that it wasn't all in her head and started to understand the scope of suffering by those whose symptoms are dismissed.   Shifting Away from Conventional Medicine Meghan's medical struggles changed course when the sister of a friend (who is a nurse) suggested that she see a functional medicine doctor. The first thing they did was run labs that no conventional doctor had even considered. This was how the thyroid anomaly was found leading to a diagnosis of Hashimoto's disease.  Even though she was starting to get answers, it was difficult for her to let go of the belief that conventional doctors were the ultimate authority on health. Many people experience this because we are raised to trust traditional medicine and to be skeptical of alternatives. But, the more she started to view her body as a whole system, the more she was able to understand the role the individual symptoms were playing in her overall health picture. She started to figure out the root causes of her symptoms.   Lyme Disease Diagnosis Lyme disease had been the root cause of several of her symptoms. She'd had a number of strange rashes at different times but they weren't classic bullseye rash known to indicate Lyme. She had dismissed Lyme as a possibility because of the lack of this tell-tale rash. It turns out that many people go undiagnosed for this same reason. The longer you have Lyme without treating it, the more damage it can do.  Meghan was hesitant to treat her Lyme disease with antibiotics because she found that certain lifestyle choices significantly helped reduce her symptoms. However, this state of being “almost symptom-free” didn't always last. Her functional doctor convinced her that the medication was necessary. Many people are surprised by this but the risks of Lyme going untreated are seen as far more harmful than the negative impact on your gut flora from taking antibiotics. It took some time for the medication to work, but once it did, she was able to focus on repairing the damage the antibiotics may have done to her gut health.    Fecal Microbiota Transplant Fecal Microbiota Transplant is a cutting edge approach used to restore a severely-imbalanced gut. While this is still somewhat experimental, Meghan was willing to be a guinea pig. She's glad she did it because in the end, she found it profoundly improved her health.  But, it wasn't a rosy path. Firstly, it's an expensive treatment that is only covered (in the US) by insurance for treating C Difficile. The transplant (using a donor's fecal microbiota) process took two weeks. They warned her that there might be an immune reaction and there was. She experienced flu-like symptoms and felt ill. They adjusted the treatment due to this reaction but felt confident that it was working. Two weeks later, Meghan reports that she felt a level of energy and good health that she hadn't felt in 15 years.    A Mindset of Resilience for Autoimmune Disease One of the biggest lessons in Meghan's book is the importance of mindset when you're dealing with chronic illness and autoimmune diseases. She shares in her book coping mechanisms and a strategy for surviving it. The focus is so often on the physical challenges and we end up disregarding the mental and emotional challenges being faced.  This can sometimes include a lack of trust in the medical system and even in what you're feeling.    Trust Your Intuition and Advocate for Yourself One of the strategies Meghan talks about is trusting your intuition so you can be an advocate for your own health. She said it played an important role especially when she was feeling overwhelmed and getting mixed messages from the various experts.  However, she points out that you want to avoid ‘search fatigue' where you spend so much time researching, finding partial answers and getting frustrated. This can cause stress and sometimes you need to take a break.  You also need to advocate for yourself outside of your treatment. You need care. You need access to better diagnostics. You need your job and for your bosses to support you and understand your disability. And, you need that social safety net and the promise of future treatment. And all of these needs can't be met if you stay invisible in your struggles. So, you need to advocate for yourself.  The Power of Tracking One of the most important strategies for Meghan was to track everything. This gave her a clearer, objective picture than memory could and also helped her understand what was happening over time.  She does this using spreadsheets where she puts her main symptoms and then rates them on a scale of 1-10 each day. She'll also add a comment or too about how she's feeling or activities that may have impacted her rating (like eating out or enjoying a glass of wine). It might sound like a lot of work, but once it is part of a routine, it doesn't take that long and it provides a clear picture of health.  Tracking can really help you make informed decisions about things that may shift the balance, like having that glass of wine, staying up a bit later, or eating out at a restaurant with friends.    Finding Balance and Peace with Your Auto-immunity One of the biggest challenges those dealing with autoimmunity face is the feeling that things will never get better. Meghan advises to consider that many of your restrictions or changes are temporary. Remember, you need to commit to it for a time but there will be a time beyond it. So, when you're feeling isolated because you can't go out to eat with friends, for example, remember that it's a temporary situation.  There will be times when you are triggered and times when you are feeling good. Everything is temporary, so don't catastrophize, but do insist on the reality of what I'm experiencing.  And remember, there are others dealing with what you're dealing with. Meghan found that her online community was helpful because you are never alone.    Eliminating Health Mysteries For Meghan, the road was long but because she continued to dig, didn't listen to those who told her to ignore her symptoms and she advocated for herself, she has regained her health. If this sounds familiar or there's someone you know who is suffering from the isolation caused by conventional medical dismissal, please share this episode.    Links: Thanks to my guest Meghan O'Rourke. You can connect with her through her website, on Twitter and on Instagram. If you'd like to pick up her book, you can find it here.    Related Podcast Episodes: An Underlying Cause of Autoimmunity and Inflammation w/ Dr. Don Wood Solving the Autoimmunity Mystery w/ Inna Topiler The Case of the Unlikely Lyme Disease w/ Dr. Darin Ingels Thanks for Listening If you like what you heard, please rate and review this podcast. Every piece of feedback not only helps me create better shows, it helps more people find this important information. Never miss an episode -  Subscribe NOW to Health Mysteries Solved with host, Inna Topiler on Apple Podcasts, Spotify, Stitcher or Google Podcasts and remember to rate and review the show! Find out more at http://healthmysteriessolved.com PLEASE NOTE All information, content, and material on this podcast is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Some of the links provided are affiliate links. This means we may make a very small amount of money should you choose to buy after clicking on them. This will in no way affect the price of the product but it helps us a tiny bit in covering our expenses. 

Fecal transplants or FMT are only allowed in the US for recurrent C Difficile infections. Hear from Sabine Hazan, MD, a researcher who conducts clinical trials using FMT and lead author of the 2020 book “Let's Talk Shit: Disease, Digestion and Fecal Transplants” about her experience with FMT (versus antibiotics) for C Diff, the importance of gut health, Covid and the microbiome, incidental conditions that have improved while conducting FMT, including alopecia areata and Alzheimer's, and current clinical trials underway with FMT for various conditions from autism to IBD. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Twitter, Instagram or Pinterest or reach her via email at lindsey@highdeserthealthcoaching.com to set up a free 30-minute Gut Healing Breakthrough Session. Show Notes